These compounds may interact with:
Proto-oncogene tyrosine-protein kinase receptor Ret
Potentially involved in: paraganglioma; hirschsprung's disease; lung cancer; cancer; breast cancer; thyroid cancer; kidney cancer; carcinoma; adrenal gland cancer; intestinal disease; adrenal medulla cancer; multiple endocrine neoplasia type 2a; multiple endocrine neoplasia type 2b; hyperparathyroidism; phaeochromocytoma; von hippel-lindau disease; persistent generalized lymphadenopathy; renal agenesis; adenoma; goiter
Disease data sourced from Pharos.